132 related articles for article (PubMed ID: 22502765)
1. Effects of clinical and laboratory variables at admission and of in-hospital treatment with cardiovascular drugs on short term prognosis of ischemic stroke. The GIFA study.
Tuttolomondo A; Di Raimondo D; Di Sciacca R; Pedone C; La Placa S; Arnao V; Pinto A; Licata G
Nutr Metab Cardiovasc Dis; 2013 Jul; 23(7):642-9. PubMed ID: 22502765
[TBL] [Abstract][Full Text] [Related]
2. Effects of clinical and laboratory variables and of pretreatment with cardiovascular drugs in acute ischaemic stroke: a retrospective chart review from the GIFA study.
Tuttolomondo A; Di Sciacca R; Di Raimondo D; Pedone C; La Placa S; Pinto A; Licata G
Int J Cardiol; 2011 Sep; 151(3):318-22. PubMed ID: 20598761
[TBL] [Abstract][Full Text] [Related]
3. Predictors of outcome in acute ischemic cerebrovascular syndromes: The GIFA study.
Tuttolomondo A; Pedone C; Pinto A; Di Raimondo D; Fernandez P; Di Sciacca R; Licata G;
Int J Cardiol; 2008 Apr; 125(3):391-6. PubMed ID: 17490764
[TBL] [Abstract][Full Text] [Related]
4. Antiplatelets, ACE inhibitors, and statins combination reduces stroke severity and tissue at risk.
Kumar S; Savitz S; Schlaug G; Caplan L; Selim M
Neurology; 2006 Apr; 66(8):1153-8; discussion 1135. PubMed ID: 16636230
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of use of cardiovascular drugs in 499 patients with suspected coronary artery disease at time of hospitalization for coronary angiography and in 357 patients with obstructive coronary artery disease documented by coronary angiography.
Mazar M; Schair B; Aronow WS; Khalique O; Lehrman SG
Am J Ther; 2008; 15(5):458-60. PubMed ID: 18806522
[TBL] [Abstract][Full Text] [Related]
6. High prevalence of previous antiplatelet drug use in patients with new or recurrent ischemic stroke: Buffalo metropolitan area and Erie County stroke study.
Qureshi AI; Kirmani JF; Safdar A; Ahmed S; Sayed MA; Pande RU; Ferguson R; Hershey LA; Qazi KJ
Pharmacotherapy; 2006 Apr; 26(4):493-8. PubMed ID: 16553507
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin 2 type 2 receptor activity and ischemic stroke severity.
Ovbiagele B; Kidwell CS; Starkman S; Selco SL; Rajajee V; Razinia T; Saver JL
Neurology; 2005 Sep; 65(6):851-4. PubMed ID: 16186522
[TBL] [Abstract][Full Text] [Related]
8. Effect of prestroke use of angiotensin-converting enzyme inhibitors alone versus combination with antiplatelets and statin on ischemic stroke outcome.
Hassan Y; Al-Jabi SW; Aziz NA; Looi I; Zyoud SH
Clin Neuropharmacol; 2011; 34(6):234-40. PubMed ID: 21996648
[TBL] [Abstract][Full Text] [Related]
9. Use of Antihypertensive Drugs and Ischemic Stroke Severity - Is There a Role for Angiotensin-II?
Hwong WY; Bots ML; Selvarajah S; Abdul Aziz Z; Sidek NN; Spiering W; Kappelle LJ; Vaartjes I
PLoS One; 2016; 11(11):e0166524. PubMed ID: 27846309
[TBL] [Abstract][Full Text] [Related]
10. Impact of the additive effect of angiotensin-converting enzyme inhibitors and /or statins with antiplatelet medication on mortality after acute ischaemic stroke.
Hassan Y; Al-Jabi SW; Aziz NA; Looi I; Zyoud SH
Basic Clin Pharmacol Toxicol; 2012 Apr; 110(4):370-7. PubMed ID: 22023326
[TBL] [Abstract][Full Text] [Related]
11. Pharmacotherapy in patients with stable coronary artery disease treated on an outpatient basis in Poland. Results of the multicentre RECENT study.
Banasiak W; Wilkins A; Pociupany R; Ponikowski P
Kardiol Pol; 2008 Jun; 66(6):642-9; discussion 650. PubMed ID: 18626833
[TBL] [Abstract][Full Text] [Related]
12. Renin-angiotensin system blockade safely reduces blood pressure in patients with minor ischemic stroke during the acute phase.
Nakamura T; Tsutsumi Y; Shimizu Y; Uchiyama S
J Stroke Cerebrovasc Dis; 2010; 19(6):435-40. PubMed ID: 20702114
[TBL] [Abstract][Full Text] [Related]
13. Risk factors profile and clinical outcome of ischemic stroke patients admitted in a Department of Internal Medicine and classified by TOAST classification.
Pinto A; Tuttolomondo A; Di Raimondo D; Fernandez P; Licata G
Int Angiol; 2006 Sep; 25(3):261-7. PubMed ID: 16878074
[TBL] [Abstract][Full Text] [Related]
14. Effect of an educational program on the prevalence of use of antiplatelet drugs, beta blockers, angiotensin-converting enzyme inhibitors, lipid-lowering drugs, and calcium channel blockers prescribed during hospitalization and at hospital discharge in patients with coronary artery disease.
Sanal S; Aronow WS
J Gerontol A Biol Sci Med Sci; 2003 Nov; 58(11):1046-8. PubMed ID: 14630888
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin II type 1 receptor blockade: high hopes sent back to reality?
Grothusen A; Divchev D; Luchtefeld M; Schieffer B
Minerva Cardioangiol; 2009 Dec; 57(6):773-85. PubMed ID: 19942847
[TBL] [Abstract][Full Text] [Related]
16. Ischemic stroke in patients receiving aspirin.
Pujol Lereis VA; Ameriso S; Povedano GP; Ameriso SF
J Stroke Cerebrovasc Dis; 2012 Nov; 21(8):868-72. PubMed ID: 21703876
[TBL] [Abstract][Full Text] [Related]
17. Safety of antiplatelet therapy prior to intravenous thrombolysis in acute ischemic stroke.
Uyttenboogaart M; Koch MW; Koopman K; Vroomen PC; De Keyser J; Luijckx GJ
Arch Neurol; 2008 May; 65(5):607-11. PubMed ID: 18332238
[TBL] [Abstract][Full Text] [Related]
18. Improvements in long-term mortality after myocardial infarction and increased use of cardiovascular drugs after discharge: a 10-year trend analysis.
Setoguchi S; Glynn RJ; Avorn J; Mittleman MA; Levin R; Winkelmayer WC
J Am Coll Cardiol; 2008 Apr; 51(13):1247-54. PubMed ID: 18371553
[TBL] [Abstract][Full Text] [Related]
19. Effect of intravenous tirofiban and aspirin in reducing short-term and long-term neurologic deficit in patients with ischemic stroke: a double-blind randomized trial.
Torgano G; Zecca B; Monzani V; Maestroni A; Rossi P; Cazzaniga M; Manganaro D; Boiti C; Zilioli E; Borutti G; Falaschi F; Mandelli C
Cerebrovasc Dis; 2010 Feb; 29(3):275-81. PubMed ID: 20090319
[TBL] [Abstract][Full Text] [Related]
20. Low cholesterol, statins and outcomes in patients with first-ever acute ischemic stroke.
Koton S; Molshatzki N; Bornstein NM; Tanne D
Cerebrovasc Dis; 2012; 34(3):213-20. PubMed ID: 23006641
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
